P. Zatloukal (Prague, Czech Republic), E. Quoix (Strasbourg, France)
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
C. Mascaux, B. Martin, M. Paesmans, T. Berghmans, A. Haller, A. P. Meert, M. Dusart, P. Lothaire, J. J. Lafitte, J. P. Sculier (Brussels, Belgium; Lille, France)
|   |
ABCG2 is determinant to SN-38 resistance in non-small cell lung cancer
Y. Bessho, T. Oguri, S. Sato, H. Achiwa, H. Muramatsu, H. Maeda, T. Niimi, R. Ueda (Nagoya, Japan)
| |
Prognostic value of circulating MUC1/KL-6 with selectin ligands in patients with lung adenocarcinoma
J. Inata, A. Yokoyama, K. Mitsuta, T. Nakashima, H. Shohda, H. Ohnishi, M. Miyazaki, N. Kohno (Hiroshima, Japan)
| |
Polymorphism of the MUC1 mucin gene is associated with susceptibility to lung adenocarcinoma and poor prognosis
K. Mitsuta, A. Yokoyama, K. Kondo, M. Nakajima, M. Miyazaki, K. I. Arita, N. Kohno (Hiroshima, Japan)
| |
The effect of polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) on lung cancer outcome
U. Gonlugur, H. Pinarbasi, T. E. Gonlugur, Y. Silig (Sivas, Turkey)
| |
The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance
C. Zhou, Y. Li, J. Xu, O. Ming (Guangzhou, China)
| |
Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer
K. Y. Chen, L. N. Lee, C. J. Yu, Y. C. Lee, S. H. Kuo, P. C. Yang (Taipei, Taiwan, Province Of China)
| |
Preoperative physiological data and lung cancer surgery: do the same factors predict post-operative morbidity/mortality and long term survival?
T. Win, L. Sharples, A. Jackson, A. J. Ritchie, F. C. Wells, C. M. Laroche (Cambridge, United Kingdom)
| |